• Nenhum resultado encontrado

Rev. bras. farmacogn. vol.27 número4

N/A
N/A
Protected

Academic year: 2018

Share "Rev. bras. farmacogn. vol.27 número4"

Copied!
8
0
0

Texto

(1)

w ww . e l s e v i e r . c o m / l o c a t e / b j p

Review

Pharmacological

potential

of

Maytenus

species

and

isolated

constituents,

especially

tingenone,

for

treatment

of

painful

inflammatory

diseases

Clarice

C.

Veloso

a,∗

,

Gutemberg

L.

Soares

a

,

Andrea

C.

Perez

b

,

Vanessa

G.

Rodrigues

c

,

Fernando

C.

Silva

c

aFaculdadedeCiênciasFarmacêuticas,UniversidadeFederaldoAmazonas,Manaus,AM,Brazil

bDepartamentodeFarmacologia,InstitutodeCiênciasBiológicas,UniversidadeFederaldeMinasGerais,BeloHorizonte,MG,Brazil cDepartamentodeQuímica,UniversidadedoEstadodeMinasGerais,Divinópolis,MG,Brazil

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received27September2016 Accepted14February2017 Availableonline2April2017

Keywords: Maytenus

Tingenone Inflammation Pain

a

b

s

t

r

a

c

t

Usesofmedicinalplantsbypeoplearoundtheworldsignificantlycontributeandguidebiologicallyactive compoundsresearchthatcanbeusefulinthecombatagainstvariousdiseases.Duetoagreatchemicaland structuralvarietyfoundintheirvegetalstructuresitconsolidatesethnopharmacologyasanimportant scienceforthepharmaceuticalsection.Insertedinthediversityofmedicinalplants,istheMaytenus genus,whoseresearchhasalreadyrevealedlotsofisolatedsubstanceswhichareresponsibleforagreat varietyofbiologicalactivities,amongwhichweciteanalgesicandanti-inflammatory,forthetreatment ofinflammatorydiseasessuchasrheumatoidarthritis,gastritis,ulcersandgastrointestinaldisorders. TheaimofthisreviewarticleistomakeacompendiumoftheMaytenusgenusanditsisolatedchemical compounds,amongthemtingenone.Theelucidationofitsmechanismofactionrevealspromisingsources forthedevelopmentofnewdrugsspeciallytargetedforthetreatmentofpainfulinflammatorydiseases. ©2017SociedadeBrasileiradeFarmacognosia.PublishedbyElsevierEditoraLtda.Thisisanopen accessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/4.0/).

Medicinalplants:sourcefordiscoveryofnewdrugs

Research for the treatment of the main diseases that affect thehumankind isa constant concernof thepopulation, whose information is proven by the numerous records found in the firstcivilizationsthatlivedonEarth(CalixtoandSiqueira,2008). AncientcivilizationsuchasChinese,IndianandNorthAfricanhave providedwrittenevidencefromtheoriginofmanusingplantsfor thetreatmentofagreatvarietyofdiseases.InOldGreece,for exam-ple,scholarsclassifiedplantsandgavedescriptionsthathelpedin theidentificationprocess(Phillipson,2001).

Nowadays,treatmentthroughmedicinalplantsplaysa funda-mentalroleinthehealthsystemsofmanycountries(Bhatiaetal., 2014).Researchesofmedicinalplantsarebecomingmore impor-tantinthedevelopmentofhealthcareandmaintenanceprograms indifferentpartsoftheworld(Shiletal.,2014).

Brazilianbiodiversitycomprises morethan50,000speciesof vascularplants(20–22%oftheexistenttotalintheplanet)and,due tothis,theinterestinstudiesofmedicinalpropertiesofplantsare exploredbyBrazilianresearchersandthepharmaceuticalindustry

∗ Correspondingauthor.

E-mail:clariceveloso@ufam.edu.br(C.C.Veloso).

(CalixtoandSiqueira,2008).Plant-derivedmedicinesforma sig-nificantsegmentrelatedtopharmaceuticalproducts,since,25%of prescribeddrugsareoriginatingfromplants(Schmidtetal.,2007). Therefore,naturalproductsarestillrepresentingavaluablesource ofinspirationforchemicals,workingwithsynthesisofbiological activecompounds,developingnewdrugs(Jietal.,2009).

Materialsandmethods

ThisreviewwaspreparedbydatabasesPubmed,GoogleScholar, ScienceDirectandSciFinderonperiodSeptember2014toJanuary 2017.ThekeywordsutilizedwereMaytenus,chemicalcompounds, tingenoneandpharmacologicalactivities.

TheCelastraceaefamily

The Celastraceae family is formedby 106 genera and 1300 species, that are widely distributed in tropical and subtropical regionsoftheworld,includingNorth Africa,SouthAmericaand eastAsia,mainlyChina(Spiveyetal.,2002;Simmonsetal.,2008; Nú ˜nez et al., 2016). It is also commonly known, as a bitter-sweetfamily,duetoitsfruits’flavor(Gonzalezetal.,2000).The plantsofthisfamilyareingeneral,characterizedbysmalltrees, bushesorlianas(Spiveyetal.,2002).Representativegenusofthis

http://dx.doi.org/10.1016/j.bjp.2017.02.006

(2)

familyareMaytenus,Euonymus,CassineandCelastrus(Perestelo, 2009), thatarestudiednotonlybecauseoftheiruseinpopular medicine, but also, because of the largegeographical distribu-tion,diversityandstructuralcomplexityoftheisolatedsecondary metabolites(Coppedeetal.,2014).Manyspeciesfromthe Celas-traceaefamily are widelystudied,except for Zinowiewiagenus whosestudiesareveryoutdatedprobablyduetoitspoor phyto-chemicalandethnopharmacologicalcharacterization(Nú ˜nezetal., 2016).

TheCelastraceae family includes various plants species, and itsextractshave beenusedfor thetreatmentofstomach com-plications,fever,appetitesuppressants,rheumatoidarthritisand cancer(Spiveyetal.,2002).TheTripterygiumwilfordiispecie,largely usedinChinaduetoitsinsecticidalproperties,isoneofthemost

studiedfromthis familyand hasseveralisolatedbioactive sub-stances(Brinkeretal.,2007).Extractsofthisspeciesareusedforthe rheumatoidarthritis,autoimmunesicknessesandskininfections (WangandXie,1999).

(3)

TheMaytenusgenus

InBrazil,76specieswerefoundindifferenthabitats,likethe Atlanticforest(M.distichophylla,M.macrophylla), altitudeforest (M.erythroxylon),rockfields(M.opaca)andinregionswithcaatinga vegetation(M.truncata,M.imbricata,M.ilicifolia,M.catingarum,M. impressa,M.obtusifolia),predominantlydistributedbetweenBahia andCearástate(Rochaetal.,2004;Nieroetal.,2011).

ThenameMaytenusisderivedfromtheword“Maytén”,used bythe“Mapuche”populationfromChile,whichmeans“manof theland”(Nieroetal.,2011).Numerousmedicinalusesare asso-ciatedtotheMaytenusgenusspecies,withtheuseofroots,barks andleavesforthetreatmentofgastriculcers,anti-inflammatory, analgesic,anti-allergy,antitumor,amongothersinSouthAmerica (Sosaetal.,2007;Baggioetal.,2009;Nieroetal.,2011;Martins etal.,2012).TheleavesoftheseveralexistentspeciesofMaytenus

inBrazil,aretraditionallyusedbyIndiansasinfusionagainst gas-tricaffections(hyperacidity,gastriculcers,duodenalandchronic gastritis)(Rochaetal.,2004).AsshowninBox1,Maytenusgenusis widelyusedinfolkmedicineforthetreatmentofvariousdiseases. ExtractsandisolatedsubstancesoftheMaytenusgenusspecies presentarangeofbiologicalactivities.Amongthe76knownspecies oftheMaytenusfoundinBrazil,only15%hadtheir pharmacolog-icaleffectsstudied(Nieroetal.,2011), andmostofthesewere performedinanimal modelsofpainand inflammation. Accord-ingtotheliterature,theethanolicextractoftheM.putterlickoides

rootspresentsantileukemicactivity(Schnebergetal.,2001),the methanolextractofM.senegalensisroots’barksshows antibacte-rialactivity(Lindseyetal.,2006)andthechloroform,hexaneand methanolicextractsoftherootspresentanti-inflammatory activ-ity,decreasingearedemainducedbycrotonoilinmice(Sosaetal., 2007).Anotherstudyshowedthatthehydroalcoholicextractof

M.robustaleavespresentsgastroprotectiveproperty(DeAndrade etal.,2007).Theethyl-acetateandmethanolicextractsoftheleaves ofM.truncatashowanalgesicandantiulceractivities(Fonsecaetal., 2007),theethanolicextractoftheM.rigidaleavespresents anti-inflammatory,antiulcerandantidiarrhealactivities(Santosetal., 2007).Inadditiontotheseeffects,M.rigidaalsopresented antinoci-ceptive effect (Martins et al., 2012)and M. heterophylla specie showedanti-inflammatoryeffect(DaSilvaetal.,2011).

BiologicalactivitiesofvariousspeciesofMaytenusgenusplants arebeingstudied.A largenumber ofstudies onM. ilicifoliaare foundinliterature,oneofthemostcommonlyused,andherbal medicinepreparedfromthisspecieisalreadycommercially avail-ableforthetreatmentofgastriculcers.Thisspecieisnativetothe SouthernpartofBrazil,Paraguay,UruguayandnorthernArgentina andhasbiologicalactivitiesbesidesitsornamentaluse. Prelimi-narystudiesofthehexaneandethylacetateextractsofM.ilicifolia

leavesinhibited the second phase of theformalin test in mice and paw edema induced by carrageenan in rats. Beside these effects,protectionagainstgastriclesionswasalsoobserved(Jorge etal.,2004;Lemeetal.,2013).Thisplantispopularlyknownas

Box1:TheMaytenusgenusanditsusesinfolkmedicine.

Scientificname Popularname Therapeuticalindications Authors

M.accuminata – Digestivesysteminflammationand

pain,chestpain

Ahmedetal.,2013

M.acuminate – Sorethroat,stomachdiseases ChukwujekwuandVanStaden,2016

M.aquifolium “Espinheira-santa”,“cancerosa” Gastricproblems Calouetal.,2014

M.cassineformis “Corac¸ão-de-bugre” Fever Schwanz,2012

M.dasyclada “Corac¸ão-de-negra” Fever Schwanz, 2012

M.distichophylla “Casca-amarela”,“pau-colher” Treatmentofstomachulcers Duarte, 2013

M.erythroxylon “casca-grossa”,“bom-nome” Antidiarrheal Formiga,2016

M.emarginata “Kankero”,“thornystafftree” Toothache,sores,jaundice Sagwanetal.,2011

M.guyanensis “Chichuá” Rheumatism,arthritis,

hemorrhoids,skinrashes

Conceic¸ão,2010;Vargasetal.,2016

M.heterophylla – Digestivesysteminflammationand

pain,chestpain

Ahmedetal.,2013

M.hookeri – Inflammations Suetal.,2013

M.ilicifolia “Espinheira-santa”,“cancerosa”,

“cancerosa-de-sete-espinhos”,“maiteno”

Gastritis,ulcers,dyspepsia,pain, wounds

Lemeetal.,2013;Calouetal.,2014

M.macroparca(M. krukovii)

“Chuchuhuasi”,“chuchuguaso” Backpain,stomachpain,sore throat,rheumatism, gastrointestinaldiseases

Torpoccoetal.,2007;Salazaretal., 2008;Llumiluiza,2013;Roblesetal., 2014

M.obtusifolia “carne-de-anta”,“carrancudo”,

“bom-nome”

Treatmentofulcer,general inflammationsandcancer

Sousa and Almeida, 2005; Mota etal.,2008

M.peduncularis – Digestivesysteminflammationand

pain,chestpain

Ahmedetal.,2013

M.procumbens – Digestivesysteminflammationand

pain,chestpain

Ahmedetal.,2013

M.rigida “Bom-nome”,“bom-homem”,

“cabelo-de-negro”,“casca-grossa”, “pau-de-colher”,“chapéu-de-couro”

Inflammation,pain,rheumatism, infections,healingprocess

Limaetal.,2010;Vieira,2013

M.robusta – Gastriculcer Silvaetal.,2015

M.royleanus – Toothache,arthritis,gastrointestinal

diseases

Shabbiretal.,2013;Shabbiretal., 2015

M.salicifolia “Cafezinho” Gastriculcers Magalhãesetal.,2011

M.senegalensis – Malaria,fever,chestpain,

rheumatism,wounds,snakebites, sorethroat,stomachdiseases

Conceic¸ão, 2010; Ahmed et al., 2013; Malebo et al., 2015; ChukwujekwuandVanStaden,2016

M.spinosa “Abriboca” Stomachdiseases Gutiérrez-Nicolásetal.,2014

M.truncata “Todo-lado”,“todo-jeito”,

“árvore-de-natal”

Gastriculcers Fonsecaetal.,2007

M.undata “Blakelock”,“kokoboom”,“koko-tree”,

“idohame”,“egqwabali”,“ikhukhuze”, “indabulovalo”,“inqayi-elibomvu”

Digestivesysteminflammationand pain,chestpain

(4)

“erva-cancerosa”, “espinho-de-deus”, “salva-vidas”, “espinheira-santa”,amongothernames(Nieroetal.,2011).Espinheira-santa isalsoapopularnameforotherspecies,suchas:M.aquifolium,M. robustaandM.truncada,becauseoftheirmarkedmorphological similarity.Theseplantshavethetraditionaluseforthetreatment ofdiabetes,kidneyproblems,treatmentofgastriculcers,as anti-inflammatoryandanalgesic(Rochaetal.,2004;Nieroetal.,2011; Lemeetal.,2013).M.obtusifolia,M.heterophylla,M.undataandM. putterlickioidesspeciespresentantiplasmodialactivity.M. hetero-phyllaisusedinAfricabyhealersforthetreatmentofherniaand syphilisandanthelmintic(Muthauraetal.,2015).Maytenus gono-clada,knownas“tiuzinho”,isaBrazilianplantfoundincerradoand rupestrianfields.Sometriterpenesofthisspeciewereisolatedand evaluated,provingagiardicidalactivity(Silvaetal.,2012).

Thinkingabout possible new and future treatments for the Alzheimer’sdisease,Rodriguesetal.(2014)analyzedsome triter-penesisolatedfromM.imbricataandM.gonoclada.Someofthese compoundsexhibitedacetylcholinesteraseinhibitionproperties.

Some studies have reported biological activities related to

Maytenustriterpeniccompoundsinthecentralnervoussystem.A studyperformedusingtherootsofM.obtusifoliarevealed antipsy-choticeffectinthemodelofcatalepsy(DeSousaandDeAlmeida, 2005).Santoyoetal.(2015)demonstratedantipsychoticeffectand behaviormodifyingeffectinastudyusingtheMaytenusmacrocarpa

ethanolicextract.

Chemicalcompounds

Isolated constituents from species of Maytenus genus (Box 2) subjected to laboratorial tests also showed biologi-cal effects. Through phythochemical studies of plants of the

Maytenusgenus,manycompoundsclasseswereisolated, includ-ingflavonoids, pentacyclictriterpenes,alkaloids andcondensed tannins(Nieroetal.,2011).

Amongtheisolatedsecondarymetabolitesofthesespecies,the fridelane pentacyclictriterpenes, quinonamethides and lupanes havebeenisolated.Lupanes andquinonamethides deserve spe-cialmentionforpresentingimportantbiologicalactivities(Vellosa etal.,2009;Martuccielloetal.,2010).

Phytochemicalstudiesperformedfromleaves,branches,stems and roots of M. imbricata showed six pentacyclic triterpenes isolated from the roots: 11␣-hydroxylup-20(29)-en-3-one; 6-oxotingenol; 3,7-dioxofriedelane; 3-oxo-29-hydroxyfriedelane; 3␤,11␣-di-hydroxylup-20(29)-en and tingenone (Silva, 2007; Rodriguesetal.,2012).

Triterpenesaretargetedbecausetheypresentbroadspectrum ofactivities,suchas:analgesic,anticancer,anti-allergy,antiviral, amongothers (Patoˇcka, 2003).Tingenoneexpressedinsecticidal activityininvivoessays(Avillaetal.,2000),potentactivityagainst

T.cruzi(Duarteetal.,2002),antitumoractivity(Gomesetal.,2011) andantibacterialandantifungalproperties(Rodriguesetal.,2012). Sesquiterpeneswithbasicskeletondihydro-␤-agarofuran, pre-sentedinhibitoryactivityforLeishmaniaparasiteresistanttoother drugs (Delgado-Méndez et al., 2008) and fridelane triterpenes revealedantiulceractivity(Andradeetal.,2008).

AresearchbyAndradeetal.(2008)verifiedtheantiulcerogenic activityof3,15-dioxo-21␣-hydroxyfriedelane(7),atriterpene iso-latedfromM.robusta.Thiscompoundsignificantlyreducedlesion areainducedbyHCl/ethanol.Theeffectof3,15-dioxo-21␣-hydroxy friedelane(7)asan antiulcerdrugis due totriterpenes’ ability tostrengthenthedefensesofthegastrointestinaltractbyraising prostaglandinproduction,whichisimportantforgastricmucosa protection.

TypeIIarabinogalactanisapolysaccharidefoundinplantscell walls.Baggioetal.(2012)evaluatedtheprotectiveeffectofthis

Box2:IsolatedcompoundsfromMaytenusgenus.

Maytenus

genus

Isolatedcompounds Literature

M.ilicifolia Quercetrin,kaempferol, catechins,

epigalocatequin-3-gallate, epigalocatequin,fridenelol, friedelan-3-ol,friedelan-3-on, friedelin,

4-o-metilepigalocatequina,type IIarabinogalactan

Alberton,2001; Pazzini,2007; Santos-Oliveira et al., 2009; Leme etal.,2013;Calou etal.,2014;Dutra etal.,2016

M.robusta Friedelin,␤-friedelinol, 3-oxo-21␤-H-hop-22(29)-ene, 3,4-seco-friedelan-3,11␤-olide, 3␤-hydroxy-21␤-H-hop-22(29)-ene,

3,4-seco-21␤-H-hop-22(29)-en-3-oicacid,

3,4-seco-friedelan-3-oicacid, 3,15-dioxo-21alpha-hydroxy friedelane,

3,12-dioxofriedelane, 11-hydroxylup-20(29)-en-3-one, mayteine,3,7-dioxofriedelane

Silvaetal.,2015; Benvenuttietal., 2016

M.aquifolium Quercetin3-O

-␣-l-rhamnopyranosyl(1→6)-O -[␤-d-glucopyranosyl(1→3)-O -␣-l-rhamnopyranosyl(1→2)-O -␤-d-galactopyranoside,kaempferol 3-O

-␣-l-rhamnopyranosyl(1→6)-O -[␤-d-glucopyranosyl(1→3)-O -␣-l-rhamnopyranosyl(1→2)-O -␤-d-galactopyranoside,friedelin, friedelan-3-ol

Alberton,2001; Dutraetal.,2016

M.truncata Proanthocyanidin Subarnasand

Wagner,2000; Fonsecaetal.,2007

M.undata

3-Oxo-11␣-methoxyolean-12-ene-30-oicacid,

3-oxo-11␣-hydroxyolean-12-ene-30-oicacid,

3-oxo-olean-9(11),12-diene-30-oicacid,

3,4-seco-olean-4(23),12-diene-3,29-dioicacid(20-epi-koetjapic acid),

3,11-dioxoolean-12-ene-30-oic acid(3-oxo-18␤-glycyrrhetinic acid),koetjapicacid, 12-oleaneneartifact 3-oxo-11␣-ethoxyolean-12-ene-30-oic acid

Muhammadetal., 2000

Maytenus buchananii

Polpunonicacid,sitosterol, tingenone,

22ˇ-hydroxytingenone

Kutney et al., 1981

Maytenus heterophylla

1␤-Acetoxy-9␣-benzoyloxy- 2␤,6␣-dinicotinoyloxy-␤-dihydroagarofuran,␤-amyrin, maytenfolicacid, 3␣-hydroxy-2-oxofriedelane-20␣-carboxylic acid,lup-20(29)-ene-1␤,3␤-diol, (−)-4′-methylepigallocatechin,

and(−)-epicatechin

Maytenus arbutifolia

␤-Amyrin,(−)-epicatechinand (−)-4′-methylepigallocatechin

Orabiaetal.,2001

compoundisolatedfromM.ilicifoliain modelsof gastric hyper-secretionandulcer.TheresultsshowedthattypeIIarabinogalactan protectedthemucosaagainstgastriculcersinoraland intraperi-tonealroutes.

(5)

Tingenone

Aminopeptidase

Opioid

peptides

µ

,

δ

,

κ

receptors

K

ATP

K+ K+

K+ K+

K+ K+

K+ K+

K+ K+

K+ K+

K+ K+

K+

Channels

opening

GTP

cGMP

nNOS

NO

L-Arg

Soluble

guanylate

cyclase

Fig.1. Mechanismofactionproposedfortingenone.nNOS,neuronalnitricoxidesintase;l-Arg,l-arginine;NO,nitricoxide;GTP,guanosinetriphosphate;cGMP,cyclic guanosinemonophosphate;KATP,channelsforsensitivepotassiumATP.

fourgramnegativeandtwofungi(Kueteetal.,2007).Another fride-lanederived, 1,3-dioxofriedelane,hasinhibitoryactivityagainst tumorcells(Bishayeeetal.,2011).

Lupanederivativeshavemanybiologicalactivities,suchas, anti-HIV, anticancerand anti-inflammatory(Xionget al.,2010).The betulinicacid,lupanederivative,hasanti-HIVactivity.Bevirimat, asyntheticderivativeofbetulinicacid,isinthephaseIIclinical assays.Thisderivativeisthefirstofanewanti-HIVagentclass, knownasmaturationinhibitors(Lee,2010).

Lupanetriterpenesshowedpotentanti-inflammatoryactivity (Reyesetal.,2006),whilesecotriterpeneacidcompoundfromM. undatapresentedsomeeffectinthromboxaneB2 inhibitionand indecreasingthesuperoxideanionformation(Muhammadetal., 2000).

Secondarymetabolites,suchasflavonoids,triterpenes,steroids, amongothers,arefoundinMaytenusgenusspecies(Nieroetal., 2011).Theiranti-inflammatorymechanismofactionisreportedon literature.Amongtheeffects,standout:reductionofchemokines production and reduction of pro-inflammatory cytokines

TNF-␣,IL-6 and IL-1␤, inhibitoryactivity against thenuclear factor

␬B(NF-␬B),afactorthatactivatesthetranscriptionofcytokines (Matsusakaetal.,1993;Pintoetal.,2008;Datetal.,2009;Valerio andAwad,2011;Choietal.,2012;Fanetal.,2012).

To some isolated triterpenoids from Maytenus species, was assigned inhibitory effects of E2 prostaglandin (PGE2) in macrophages stimulatedwithbacterial endotoxin (Reyeset al., 2006). Antinociceptive effect was demonstrated for the triter-penesintheformalintest(Limaetal.,2005;Gaertneretal.,1999). Longhi-Balbinotetal.(2011)showedtheinvolvementoftheopioid systeminthemechanismofactionofatriterpeneintheformalin test,inwhichtheantinociceptionwasrevertedbynonspecificand specific␮,␦and␬opioidreceptorsantagonism.

InastudyofisolatedcompoundsfromM.senegalensis,Sosaetal. (2007)demonstratedanti-inflammatoryactivityforthree triter-penesderivatives,whichwerethemaytenoicacid(8),thelupenone andthe␤-amyrin.Thesesubstancessignificantlyinhibitededema inadose-dependentrelationship.Inthisresearch,themaytenoic acidshowedeffectiveness,beingtwiceasactiveasindomethacin

andeventhoughlupenoneand ␤-amyrinhadlesseffectiveness, theydemonstratedagoodbiologicalactivity.

Mattosetal.(2006)reportedantiedematogeniceffectfromam steroidthatwasabletoreducetheedematogenicresponseinduced bycarrageenan.Flavonoidsexertimportanteffectinmanybiologic systems,suchasantitumor,anti-allergy,and anti-inflammatory, amongothers(DiCarloetal.,1999).Apreviousstudyshowedthat a flavonoidcompound presented inhibitory activityagainst the NF-␬B,aproteinthatregulatesthepro-inflammatoryand inflam-matory cytokines transcription (Schmidt et al., 2010). Landolfi etal.(1984)reportedthatsomeflavonoidsblockthelipoxygenase andcyclooxygenase(COX)pathways,inhibitingtheinflammatory mediatorssuchasleukotrienesandprostaglandins.

Veloso et al. (2014a) verified antinociceptive effect of the extracts and tingenone obtained from the M. imbricata roots. Theantinociceptiveperipheralmechanismofactionoftingenone was also demonstrated. It involves opioidergic pathways acti-vation and nitric oxide (NO)/cyclic guanosine monophosphate (GMPc)/channelsforsensitivepotassiumATP(KATP)(Velosoetal., 2014b,2015)againstmechanicalhyperalgesiainducedbyE2 pros-traglandin(PGE2).Cunhaetal.(2010)demonstratedthatactivation ofthenitricoxidepathwaybymorphinewasdependentonan ini-tialstimulationofPI3K␥/AKTproteinkinaseB(AKT)thatinturn mightcausethestimulationofnNOSandanincreaseinNO pro-duction.

(6)

localantinociceptiveeffectthatwasantagonizedbynaloxone,a nonspecificantagonistfortheopioidreceptors.Clocinnamox, nal-trindoleandnor-binaltorphimine,whicharespecificantagonists forthe␮,␦and␬receptors,respectively,revertedtheperipheral antinociceptioninducedbytingenone.Bestatin,anaminopeptidase inhibitor,anenzymethatdegradesopioidpeptides,intensifiedthe antinociceptiveeffectoftingenone.Thus,theresultssuggestedthe participationoftheopioidergicsystemintheperipheral antinoci-ceptioninducedbytingenone.

Tingenone, when administrated in the right hind paw, also inducedalocalantinociceptiveeffectthatwasantagonizedby l-NOArg,anonspecificinhibitorofnitricoxidesintase(NOS),andby L-NPA,anspecificinhibitorofneuronalNOS(Velosoetal.,2015). l-NIO,anspecificinhibitoroftheendothelialisoform,andthe l-NIL,anspecificinhibitoroftheinducibleform,didnotchangethe peripheralantinociceptiveeffectoftingenone(4).ODQ,anspecific inhibitorof solubleguanylate cyclase,prevented theperipheral antinociceptive effect of tingenone, and zaprinast, a phospho-diesteraseinhibitor,enzymethatdegradesGMPc,intensifiedthe peripheralantinociceptiveeffectofthelowestdoseoftingenone. Glibenclamide,aKATPchannelblocker,butnot tetraethylammon-ium chloride, a blocker of the voltage-dependent channels for potassium;dequalinium chloride,a blocker of the activatedby smallconductancecalciumchannelsforpotassium,andpaxillin, apotentblockerofthechannelsforpotassiumactivatedbyhigh conductance calcium, prevented the peripheral antinociceptive effectof tingenone (Fig.1).The results showedthat tingenone inducedaperipheralantinociceptiveeffectbyactivationofthe l-arginine/NO/GMPc/KATPpathway,revealingapotentialtobecome anewanalgesicdrug.

Conclusion

Studies of natural products are multidisciplinary. The path involvespreliminaryexperimentaltestsofaplantcrude extract andseveralstepsthatcostalotoftimeandinvestment,beforethe mainobjective,thatisthedevelopmentofadrug(herbalor tradi-tional)thatcanreachapopulationinneed.Thisisveryimportant inpoororunderdevelopedcountriessuchasBrazilthatpresentsa bigbiodiversityandapoorpopulation.

DuetothepopularuseofMaytenusspeciesforthetreatmentof inflammatorydiseases,studiesofpharmacologicalpropertiesand characterizationofthechemicalcompoundsintheextractsand infusionsarenecessarytodefineandelucidateasafeandnon-toxic use.Thisisalsothebaseforthedevelopmentofnewdrugsfrom naturalproducts,butalwaystargetingtoelucidatethemechanism ofactionandtodisclosethebiologicalactivityandthechemical structureresponsible.

Tingenone has a big potential to become an analgesic, as demonstrated by its biological activities evaluation. It was demonstratedtheopioidergic pathway activationbytingenone, whoseperipheralantinociceptive action occursbyactivation of l-arginine/NO/cGMP/KATP pathway.This mechanismof action is associatedwithvariousopioidanalgesics.However,morestudies arerequiredtofurtherelucidateitsmechanismofactionandnew therapeuticactions.

Authors’contributions

CCV, VGR and FCS contributed with data collection and writingofthemanuscript.GLScontributedwithwritingand for-matof themanuscript. ACP participated in final editing of the manuscript.Alltheauthorscontributedtothecriticalreadingofthe manuscript.

Conflictsofinterest

Theauthorsdeclarenoconflictsofinterest.

References

Ahmed, A.S., McGaw, L.J., Eloff, J.N., 2013. Evaluation of pharmacological activities,cytotoxicity andphenoliccomposition offour Maytenusspecies usedinsouthernAfricantraditionalmedicine totreatintestinalinfections anddiarrhoeal diseases.BMC Complement.Altern. Med.,http://dx.doi.org/ 10.1186/1472-6882-13-100.

Alberton,M.D.,2001.Investigac¸ãofitoquímicadeZollerniailicifolia(Brongniart) vogel(Fabaceae):Contribuic¸ãoaocontroledequalidadedeespinheira-santa (Maytenusspp.).Dissertac¸ãodeMestrado,ProgramadePós-graduac¸ãoem Far-mácia,UniversidadeFederaldeSantaCatarina,Florianópolis,91p.

Andrade, S.F., Comunello, E., Noldin, V.F., Monache, F.D., Cechinel Filho, V., Niero,R., 2008. Antiulcerogenic activity offractions and 3,15-Dioxo-21␣-hydroxyfriedelaneisolatedfromMaytenusrobusta(Celastraceae).Arch.Pharm. Res.31,41–46.

Avilla, J.,Teixidò, A., Velázquez, C.,Alvarenga, N., Ferro, E., Canela,R., 2000.

InsecticidalactivityofMaytenusspecies(Celastraceae)nortriterpenequinone methidesagainstcodlingmoth,Cydiapomonella(L.)(Lepidoptera:Tortricidae). J.Agric.FoodChem.48,88–92.

Baggio,C.H.,Freitas,C.S.,Mayer,B.,DosSantos,A.C.,Twardowschy,A.,Potrich, F.B.,Cipriani,T.R.,deSouza,L.M.,Sassaki,G.L.,lacomini,M.,Marques,M.C., Mesia-Vela, S.,2009. Muscarinic-dependentinhibition ofgastricemptying andintestinalmotilitybyfractionsofMaytenusilicifoliaMartex.Reissek.J. Ethnopharmacol.123,385–391.

Baggio,C.H.,Freitas,C.S.,Twardowschy,A.,DosSantos,A.C.,Mayer,B.,Potrich,F.B., Cipriani,T.R.,Sassaki,G.L.,Iacomini,M.,Marques,M.C.A.,Mesia-Vela,S.,2012.

Invivo/invitrostudiesoftheeffectsofthetypeIIarabinogalactanisolatedfrom MaytenusilicifoliaMart.ExReissekonthegastrointestinaltractofrats.Z. Natur-forsch.67,405–410.

Benvenutti,D.F.,Della,Monache,F.,CechinelFilho,V.,deAndrade,S.F.,Niero,R., 2016.Phytochemicalanalysisandgastroprotectiveactivityoftherootbarkfrom Maytenusrobusta.Nat.Prod.Commun.11,597–599.

Bhatia,H.,Sharma,Y.P.,Manhas, R.K.,Kumar,K.,2014. Ethnomedicinalplants usedbythevillagersofdistrictUdhampur,J&K,India.J.Ethnopharmacol.151, 1005–1018.

Bishayee,A.,Ahmed,S.,Brankov,N.,Perloff,M.,2011.Triterpenoidsaspotential agentsforthechemopreventionandtherapyofbreastcancer.Front.Biosci.16, 980–996.

Brinker,A.M.,Ma,J.,Lipsky,P.E.,Raskin,I.,2007.Medicinalchemistryand pharma-cologyofgenusTripterygium(Celastraceae).Phytochemistry68,732–766.

Calixto,J.B.,SiqueiraJr.,J.M.,2008.DesenvolvimentodeMedicamentosnoBrasil: Desafios.GazetaMédicadaBahia78,98–106.

Calou,I.B.F.,Lima,L.A.R.,Ferreira,J.A.N.,Cerqueira,G.S.,2014.Aatividade gastropro-tetoradaMaytenusilicifoliaeMaytenusaquifolium.Rev.SaudeCienc.3,33–42.

Choi,J.N.,Choi,Y.-H.,Lee,J.-M.,Noh,I.C.,Park,J.W.,Choi,W.S.,Choi,J.H.,2012.

Anti-inflammatoryeffectsof␤-sitosterol-␤-d-glucosidefromTrachelospermum jasminoides(Apocynaceae)inlipopolysaccharide-stimulatedRAW264.7murine macrophages.Nat.Prod.Res.26,2340–2343.

Chukwujekwu, J.C., Van Staden, J., 2016. In vitro antibacterial activity of

Combretum edwardsii, Combetrum krausii, and Maytenus nemorosa and theirsynergisticeffectsincombinationwithantibiotics.Front.Pharmacol.,

http://dx.doi.org/10.3389/fphar.2016.00208.

Conceic¸ão,A.M.,2010.Efeitosantinociceptivo,anti-inflamatórioeantioxidanteda entrecascadaMaytenusrígidaMart.(Celastraceae).Dissertac¸ãodeMestrado, NúcleodePós-graduac¸ãoemMedicina,UniversidadeFederaldeSergipe, Ara-cajú,67p.

Coppede,J.S.,Pina,E.S.,Paz,T.A.,Fachin,A.L.,Marins,M.A.,Bertoni,B.W.,Franc¸a,S.C., Pereira,A.M.S.,2014.CellculturesofMaytenusilicifoliaMart.arerichersources ofquinone-methidetriterpenoidsthanplantrootsinnatura.PlantCellTissue Org.Cult.118,33–43.

Cunha,T.M.,Roman-Campos,D.,Lotufo,C.M.,Duarte,H.L.,Souza,G.R.,VerriJr.,W.A., Funez,M.I.,Dias,Q.M.,Schivo,I.R.,Domingues,A.C.,Sachs,D.,Chiavegatto,S., Teixeira,M.M.,Hothersall,J.S.,Cruz,J.S.,Cunha,F.Q.,Ferreira,S.H.,2010. Mor-phineperipheralanalgesiadependsonactivationofthePI3K␥/AKT/nNOS/KATP signalingpathway.Proc.Natl.Acad.Sci.U.S.A.107,4442–4447.

DaSilva,G.,Tanic¸a,M.,Rocha,J.,Serrano,R.,Gomes,E.T.,Sepodes,B.,Silva,O., 2011.Invivoanti-inflammatoryeffectandtoxicologicalscreeningofMaytenus heterophyllaandMaytenussenegalensisextracts.Hum.Exp.Toxicol.30,693–700.

Dat,N.T.,Thao,N.P.,Quynh,L.T.P.,Minh,C.V.,Bach,T.T.,Joon,L.J.,2009.Flavonoids fromEupatoriumodoratumasinhibitorsofNF-KB.J.Sci.Technol.47,1–6.

DeAndrade,S.F.,Lemos,M.,Comunello,E.,Noldin,V.F.,Filho,V.C.,Niero,R.,2007.

EvaluationoftheantiulcerogenicactivityofMaytenusrobusta(Celastraceae)in differentexperimentalulcermodels.J.Ethnopharmacol.113,252–257.

DeSousa,D.P.,DeAlmeida,R.N.,2005.Neuroleptic-likepropertiesofthechloroform extractofMaytenusobtusifoliaMart.Biol.Pharm.Bull.28,224–225.

(7)

DiCarlo,G.,Mascolo,N.,Izzo,A.A.,Capasso,F.,1999.Flavonoids:oldandnewaspects ofaclassofnaturaltherapeuticdrugs.LifeSci.65,337–353.

Duarte,L.P.,VieiraFilho,S.A.,Silva,G.D.,deSousa,J.R.,Pinto,A.S.,2002. Anti-trypanosomalactivityofpentacyclictriterpenesisolatedfromAustroplenckia populnea(Celastraceae).Rev.Inst.Med.Trop.SãoPaulo44,109–112.

Duarte,M.C.,2013.ConstituintesquímicosdeMaytenusdistichophyllaMart.ex Reissek.JoãoPessoa2013.TesedeDoutorado,UniversidadeFederaldaParaíba.

Dutra,R.C.,Campos,M.M.,Santos,A.R.S.,Calixto,J.B.,2016.Medicinalplantsin Brazil:pharmacologicalstudies,drugdiscovery,challengesandperspectives. Pharmacol.Res.11,24–29.

Fan,S.-Y.,Zeng,H.-W.,Pei,Y.-H.,Li,L.,Ye,J.,Pan,Y.-X.,Zhang,J.-G.,Yuan,X., Zhang,W.-D.,2012.Theanti-inflammatoryactivitiesofanextractand com-poundsisolatedfromPlatycladusorientalis(Linnaeus)Francoinvitroandexvivo. J.Ethnopharmacol.141,647–652.

Fonseca,A.P.N.D.,Silva,G.D.F.,Carvalho,J.J.,Salazar,G.C.M.,Duarte,L.P.,Silva,R.P., Jorge,R.M.,Tagliati,C.A.,Zani,C.L.,Alves,T.M.A.,Peres,V.,VieiraFilho,S.A., 2007.EstudofitoquímicododecoctodasfolhasdeMaytenustruncataReisseke avaliac¸ãodasatividadesantinociceptiva,antiedematogênicaeantiulcerogênica deextratosdodecocto.Quim.Nova30,842–847.

Formiga,R.O.,2016.Avaliac¸ãofitoquímica,toxicológicaefarmacológicadoextrato etanólicodaMaytenuserythroxylonReissek(Celastraceae).JoãoPessoa2016. TrabalhodeConclusãodeCurso,UniversidadeFederaldaParaíba.

Gaertner,M.,Muller,L.,Roos,J.F.,Cani,G.,Santos,A.R.S.,Niero,R.,Calixto,J.B., Yunes,R.A.,Monache,F.D.,Cechinel-Filho,V.,1999.Analgesictriterpenesfrom Sebastianiaschottianaroots.Phytomedicine1,41–44.

Gomes,J.P.M.,Cardoso,C.R.P.,Varanda,E.A.,Molina,J.-M.,Fernandez,M.F.,Olea, N.,Carlos,I.Z.,Vilegas,W.,2011.Antitumoral,mutagenicand(anti)estrogenic activitiesoftingenoneandpristimerin.Rev.Bras.Farmacogn.21,963–971.

Gonzalez,A.G.,Bazzocchi,I.L.,Moujir,L.,Jimenez,I.A.,2000.Ethnobotanicalusesof Celastraceaebioactivemetabolites.Stud.Nat.Prod.Chem.23,649–738.

Gutiérrez-Nicolás, F., Oberti, J.C., Ravelo, A.G., Estévez-Braun, A., 2014. ␤-AgarofuransandsesquiterpenepyridinealkaloidsfromMaytenusspinose.J.Nat. Prod.77,1853–1863.

Hou,Y.,Cão,S.,Brodie,P.,Callmander,M.,Ratovoson,F.,Randrianaivo,R., Rako-tobe,E.,Rasamison,V.E.,Rakotonandrasana,S.,TenDyke,K.,Suh,E.M.,Kingston, D.G.I.,2009.AntiproliferativecardenolideglycosidesofElaeodendron alluaudi-anumfromtheMadagascarRainforest.Bioorg.Med.Chem.17,2215–2218.

Hwang,B.Y.,Kim,H.S.,Lee,J.H.,Hong,Y.S.,Ro,J.S.,Lee,K.S.,Lee,J.J.,2001.Antioxidant benzoylatedflavan-3-olglycosidefromCelastrusorbiculatus.J.Nat.Prod.64, 82–84.

Ji,H.-F.,Li,J.-X.,Zhang,H.-Y.,2009.Naturalproductsanddrugdiscovery:can thousandsofyearsofancientmedicalknowledgeleadustonewand power-fuldrugcombinationsinthefightagainstcanceranddementia?EMBORep.10, 194–200.

Jorge,R.M.,Leite,J.P.V.,Oliveira,A.B.,Tagliati,C.A.,2004.Evaluationof antinoci-ceptive,anti-inflammatoryandantiulcerogenicactivitiesofMaytenusilicifolia. J.Ethnopharmacol.94,93–100.

Kuete, V., Nguemwving, J.R., Beng, V.P., Azebaze, A.G., Etoa, F.X., Meyer,M., Nkengfack,A.E.,2007.Antimicrobialactivityofthemethanolicextractsand compoundsfromVismialaurentiiDeWild(Guttiferae).J.Ethnopharmacol.109, 372–379.

Kutney,J.P.,Beale,M.H.,Salisbury,P.J.,Stuart,K.L.,Worth,B.R.,Townsley,P.M., Chalmers,W.T.,Nilssont,K.,Jacoli,G.G.,1981.Isolationandcharacterization ofnaturalproductsfromplanttissueculturesofMaytenusbuchananii. Phyro-chemistry20,653–657.

Landolfi, R., Mower, R.L., Steiner, M.,1984. Modification of platelet function andarachidonicacidmetabolismbybioflavonoids.Biochem.Pharmacol.32, 1525–1530.

Lee,K.-H.,2010.Discoveryanddevelopmentofnaturalproduct-derived chemother-apeuticagentsbasedonamedicinalchemistryapproach.J.Nat.Prod.73, 500–516.

Leme,T.S.V.,Prando,T.B.L.,Gasparotto,F.M.,Souza,P.,Crestani,S.,Souza,L.M., Cipri-ani,T.R.,Lourenc¸o,E.L.B.,Junior,A.G.,2013.Roleofprostaglandin/Camppathway inthediureticandhypotensiveeffectsofpurifiedfractionofMaytenusilicifolia MartexReissek(Celastraceae).J.Ethnopharmacol.150,154–161.

Lima,F.V.,Malheiros,A.,Otuki,M.F.,Calixto,J.B.,Yunes,R.A.,Filho,V.C.,Monache, F.D.,2005.ThreetriterpenesfromtheresinousbarkofProtiumkleiniiandtheir antinociceptiveactivity.J.Brazil.Chem.Soc.16,578–582.

Lima,A.P.,Leite,N.S.,Camargo,E.A.,Estevam,C.S.,Pantaleão,S.M.,Fernandes,R.P.M., Costa,S.K.P.,Muscará,M.N.,Thomazzi,S.M.,2010.Avaliac¸ãodaatividade cica-trizantedoextratoetanólicodacascadaMaytenusrigidaMart.(Celastracea). ScientiaPlena6,1–7.

Lindsey,K.L.,Budesinsky,M.,Kohout,L.,Staden,J.V.,2006.Antibacterialactivityof maytenonicacidisolatedfromtheroot-barkofMaytenussenegalensis.S.Afr.J. Bot.72,473–477.

Llumiluiza, D.F.S.,2013. Desarrollo de um medicamentoanalgésico tópicode MaytenuslaevisReissek(Chuchuguaso).Tesis,CarreradeQuímicaFarmacéutica, UniversidadCentraldelEcuador,Quito,149p.

Longhi-Balbinot,D.T.,Martins,D.F.,Lanznaster,D.,Silva,M.D.,Facundo,V.A.,Santos, A.R.S.,2011.Furtheranalysesofmechanismsunderlyingtheantinociceptive effectofthetriterpene3␤,6␤,16␤-trihydroxylup-20(29)-eneinmice.Eur.J. Pharmacol.653,32–40.

Luo,D.Q.,Zhang,X.,Tian,X.,Liu,J.K.,2004.InseticidalcompoundsfromTripterygium wilfordiiactiveagainstMythimnaseparata.Z.Naturforsch.59,421–426.

Magalhães,C.G.,Ferrari,F.C.,Guimarães,D.A.S.,Silva,G.D.F.,Duarte,L.P.,Figueiredo, R.C.,Filho,S.A.V.,2011.Maytenussalicifolia:triterpenesisolatedfromstemsand

antioxidantpropertyofextractsfromaerialparts.Rev.Bras.Farmacogn.21, 415–419.

Malebo,H.M.,Wiketye,V.,Katani,S.J.,Kitufe,N.A.,Nyigo,V.A.,Imeda,C.P.,Ogondiek, J.W.,Sunguruma,R.,Mhame,P.P.,Massaga,J.J.,Mammuya,B.,Senkoro,K.P., Rumisha,S.F.,Malecela,M.N.,Kitua,A.Y.,2015.Invivoantiplasmodialand tox-icologicaleffectofMaytenussenegalensistraditionallyusedinthetreatmentof malariainTanzania.MalariaJ.14,1–7.

Martins,M.V.,Estevam,C.S.,Santos,A.L.L.M.,Dias,A.S.,Cupertino-da-Silva,Y.K., Araújo-Júnior,J.X.,Miranda,A.L.P.,Barreiro,E.J.,Pizza,C.,Piacente,S.,Montoro, P.,Quintans-Júnior,L.J.,Araujo,B.S.,Alexandre-Moreira,M.S.,Sant’Ana,A.E.G., 2012.Antinociceptiveeffectsofanextract,fractionandanisolatedcompound ofthestembarkofMaytenusrigida.Rev.Bras.Farmacogn.22,598–603.

Martucciello,S.,Balestrieri,M.L.,Felice,F.,Estevam,C.S.,Sant’Ana,A.E.G.,Pizza, C.,Piacente,S.,2010.EffectsoftriterpenederivativesfromMaytenusrigida onVEGF-inducedKaposi’ssarcomacellproliferation.Chem.-Biol.Interact.183, 450–454.

Matsusaka,T.,Fujikawa,K.,Nishio,Y.,Mukaida,N.,Matsushima,K.,Kishimoto,T., Akira,S.,1993.TranscriptionfactorsNF-IL6andNF-␬Bsynergisticallyactivate transcriptionoftheinflammatorycytokines,interleukin6andinterleukin8. Proc.Natl.Acad.Sci.U.S.A.90,10193–10197.

Mattos,W.M.,Campos,M.M.,Fernandes,E.S.,Richetti,G.P.,Niero,R.,Yunes,R.A., Calixto,J.B.,2006.Anti-edematogeniceffectsofvelutinolAisolatedfrom Man-devillavelutina:evidenceforaselectiveinhibitionofkininB1receptor-mediated

responses.Regul.Pept.136,98–104.

Mena-Rejón,G.J.,Pérez-Espadas,A.R.,Moo-Puc,R.E.,Cedillo-Rivera,R.,Bazzocchi, I.L.,Jiménez-Diaz,I.A.,Quijano,L.,2007.Antigiardialactivityoftriterpenoids fromrootbarkofHippocrateaexcelsa.J.Nat.Prod.70,863–865.

Mokoka, T.A., McGaw, L.J., Mdee, L.K., Bagla, V.P., Iwalewa, E.O., Eloff, J.N., 2013. Antimicrobial activity and cytotoxicity of triterpenesisolated from leaves ofMaytenusundata (Celastraceae).BMCComplement.Altern.Med.,

http://dx.doi.org/10.1186/1472-6882-13-111.

Mota,K.S.L.,Pita,J.C.L.R.,Estevam,E.C.,Medeiros,V.M.,Tavares,J.F.,Agra,M.F.,Diniz, M.F.F.M.,Silva,M.S.,Batista,L.M.,2008.Evaluationofthetoxicityand antiulcero-genicactivityoftheethanolextractofMaytenusobtusifoliaMart.Leaves.Rev. Bras.Farmacogn.18,441–446.

Muhammad,I.,ElSayed,K.A.,Mossa,J.S.,Al-Said,M.S.,El-Feraly,F.S.,Clark,A.M., Hufford,C.D.,Oh,S.,Mayer,A.M.S.,2000.Bioactive12-oleanenetriterpeneand secotriterpeneacidsfromMaytenusundata.J.Nat.Prod.63,605–610.

Muthaura,C.N.,Keriko,J.M.,Mutai,C.,Yenesew,A.,Gathirwa,J.W.,Irungu,B.N., Nyangacha,R.,Mungai,G.M., Derese,S., 2015.Antiplasmodialpotentialof traditionalphytotherapyofsomeremediesusedintreatmentofmalariain Meru-TharakaCountryofKenya.J.Ethnopharmacol.175,315–323.

Niero,R.,deAndrade,S.F.,Filho,V.C.,2011.Areviewoftheethnopharmacology, phy-tochemistryandpharmacologyofplantsoftheMaytenusGenus.Curr.Pharm. Des.17,1851–1871.

Nú ˜nez,M.J.,Jiménez,I.A.,Mendonza,C.R.,Chavez-Sifontes,M.,Martinez,M.L., Ichi-ishi,E.,Tokuda,R.,Tokuda,H.,Bazzocchi,I.L.,2016.Dihydro-␤-agarofuran sesquiterpenesfrom Celastraceaespeciesasanti-tumor-promoting agents: structure–activityrelationship.Eur.J.Med.Chem.111,95–102.

Orabia,K.Y.,Al-Qasoumia,S.I.,El-Olemya,M.M.,Mossaa,J.S.,Muhammadb,I.,2001.

DihydroagarofuranalkaloidandtriterpenesfromMaytenusheterophyllaand Maytenusarbutifolia.Phytochemistry58,475–480.

Patoˇcka, J.,2003. Biologically activepentacyclic triterpenesand their current medicinesignification.J.Appl.Biomed.1,7–12.

Pazzini,D.,2007.Estudodainduc¸ãodeúlceragástricacrônicaeaguda:avaliac¸ãoda atividadeanti-ulcerogênicaeanti-oxidativadeMaytenusilicifolia(Celastraceae). Dissertac¸ãodeMestrado,ProgramadeMestradoemBiologiaOral,Universidade doSagradoCorac¸ão,Bauru,83p.

Perestelo,N.I.R.,2009.MetabolitossecundariosaisladosdeMaytenusjelskii (Celas-traceae).Estudioderelaciónestructura-actividad.TesisDoctoral,Universidad deLaLaguna,LaLaguna,387p.

Phillipson,J.D.,2001.Phytochemistryandmedicinalplants.Phytochemistry56, 237–243.

Pinto,S.A.H.,Pinto,L.M.S.,Cunha,G.M.A.,Chaves,M.H.,Santos,F.A.,Rao,V.S.,2008.

Anti-inflammatoryeffectof␣,␤-amyrin,apentacyclictriterpenefromProtium heptaphylluminratmodelofacuteperiodontitis.Inflammopharmacology16, 48–52.

Reyes,C.P.,Nú ˜nez,M.J.,Jiménez,I.A.,Busserolles,J.,Alcaraz,M.J.,Bazzocchi,I.L., 2006.ActivityoflupanetriterpenoidsfromMaytenusspeciesasinhibitorsof nitricoxideandprostaglandinE2.Bioorg.Med.Chem.14,1573–1579.

Roberts,S.C.,2007.Productionandengineeringofterpenoidsinplantcellculture. Nat.Chem.Biol.3,387–395.

Robles,P.V.,Tarqui,C.L.,Rodrígues,C.N.,Morales,C.A.,DeLaCruz,M.J.,Ríos,M.K., Rivera,C.D.,Rubio,G.A.,Cruz,C.C.S.,Velazco,C.G.,Loja,H.B.,Alvarado,Y.A., Casta ˜neda,C.B.,Salazar,G.A.,2014.Efectoantinociceptivodelextractoetanólico delashojasdeMaytenusmacrocarpa(Ruiz&Pav.)Briq.“chuchuhuasi”mediante lapruebadecontorsionesabdominalesenratones.Rev.Horiz.Med.14,6–10.

Rocha,C.S.,Pimentel,R.M.M.,Randau,K.P.,Xavier,H.S.,2004.Morfoanatomiade folhasdeMaytenusrigidaMart.(Celastraceae);umaespécieutilizadacomo medicinalnonordestedoBrasil.ActaFarm.Bonaer.23,472–476.

Rodrigues,V.G.,Duarte,L.P.,Silva,G.D.F.,Silva,F.C.,Góes,J.F.,Takahashi,J.A.,Pimenta, L.P.S.,2012.Evaluationofantimicrobialactivityandtoxicpotentialofextracts andtriterpenesisolatedfromMaytenusimbricata.Quim.Nova35,1375–1380.

(8)

Sagwan,S.,Rao,D.V.,Sharma,R.A.,2011.Maytenusemarginata(Willd.):apromising drugforcancertherapy.AsianJ.Pharm.Clin.Res.4,9–12.

Salazar,G.A.,Milla,F.D.,Morales,G.V.,Velarde,B.L.,Villanueva,E.A.,Segura,C.K., Casquero,D.D.,Vargas,P.Y.,Vela,G.Y.,Sánchez,A.V.,Manrique,M.R.,2008. Eval-uacióndelaactividadehipotensoradelMaytenuskrukovii(Chuchuhuasi)emrata consciente.Rev.Horiz.Med.8,41–47.

Santos-Oliveira,R.,Coulaud-Cunha,S.,Colac¸o,W.,2009.RevisãodaMaytenus ilici-foliaMart.ExReissek,Celastraceae.Contribuic¸ãoaoestudodaspropriedades farmacológicas.Rev.Bras.Farmacogn.19,650–659.

Santos,V.L.,Costa,V.B.M.,Agra,M.F.,Silva,B.A.,Batista,L.M.,2007.Pharmacological studiesofethanolicextractsofMaytenusrigidaMart(Celastraceae)inanimal models.Rev.Bras.Farmacogn.17,336–342.

Santoyo,C.Z.,Espinoza,L.Z.,Puente,R.Z.,Sánchez,J.Z.,Quispe,N.Z.,Medina,C.P., Granara,S.A.,2015.Antipsychoticandbehavioreffectoftheethanolicextract fromthebarkofMaytenusmacrocarpa(Ruiz&Pav.)Briq.inmice.Pharmacogn. Commun.5,244–249.

Schmidt,B.M.,Ribnicky,D.M.,Lipsky,P.E.,Raskin,I.,2007.Revisitingtheancient conceptofbotanicaltherapeutics.Nat.Chem.Biol.3,360–366.

Schmidt,C.A.,Murillo, R.,Bruhn, T., Bringmann, G.,Goettert,M., Heinzmann, Brecht, V., Laufer, S.A.,Merfort, I.,2010. Catechinderivatives from Para-piptadeniarigidawith invitrowound-healing properties.J. Nat.Prod.73, 2035–2041.

Schneberg, B.T., Green, D.K., Sneden, A.T., 2001. Dihydroagarofuran sesquiterpene alkaloid from Maytenus putterlickoides. J. Nat. Prod. 64, 624–626.

Schwanz,M.,2012.Avaliac¸ãoquímicaebiológicadeMaytenusdasycladaMart.e MaytenuscassineformisReissek(Celastraceae).TesedeDoutorado,Universidade FederaldoRioGrandedoSul,PortoAlegre,226p.

Shabbir,M.,Khan,M.R.,Saeed,N.,2013.Assessmentofphytochemicals, antiox-idant, anti-lipid peroxidation and anti-hemolytic activity of extract and variousfractionsofMaytenusroyleanusleaves.BMCComplement.Altern.Med.,

http://dx.doi.org/10.1186/1472-6882-13-143.

Shabbir,M.,Syed, D.N.,Lall, R.K.,Khan,M.R., Mukhtar,H.,2015. Potent anti-proliferative,pro-apoptoticactivityoftheMaytenusroyleanusextractagainst prostatecancercells:evidenceinin-vitroandin-vivomodels.PLOSONE10, 1–20.

Shil,S.,Choudhury,M.D.,Das,S.,2014.Indigenousknowledgeofmedicinalplants usedbytheReangtribeofTripurastateofIndia. J.Ethnopharmacol.152, 135–141.

Silva,S.R.S.,2007.Estudoquímicoeavaliac¸ãodopotencialfarmacológicoe her-bicidadeMaytenusimbricataMart.ex.Reissek.BeloHorizonte2007.Tesede Doutorado,UniversidadeFederaldeMinasGerais.

Silva,F.C.,Busatti,H.G.N.O.,Gomes,M.A.,Duarte,L.P.,Silva,G.D.F.,Filho,S.A.V.,2012.

AntigiardialactivityofthehexaneextractsofMaytenusgonocladaMart.Int.J. Pharm.Pharm.Sci.4,638–639.

Silva,L.M.,Boeing,T.,Somensi,L.B.,Cury,B.J.,Steimbach,V.M.B.,Silveira,A.C.O., Niero,R.,Filho,V.C.,Santin,J.R.,DeAndrade,S.F.,2015.Evidenceofgastric ulcerhealingactivityofMaytenusrobustaReissek:invitroandinvivostudies. J.Ethnopharmacol.175,75–85.

Simmons,M.P.,Cappa,J.J.,Archer,R.H.,Ford,A.J.,Eichstedt,D.,Clevinger,C.C.,2008.

PhylogenyoftheCelastreae(Celastraceae)andtherelationshipsofCathaedulis (qat)inferredfrommorphologicalcharactersandnuclearandplastidgenes.Mol. Phylogenet.Evol.48,745–757.

Sosa,S.,Morelli,C.F.,Tubaro,A.,Cairoli,P.,Speranza,G.,Manitto,P.,2007. Anti-inflammatoryactivityofMaytenussenegalensisrootextractsandofmaytenoic acid.Phytomedicine14,109–114.

Sousa,D.P.,Almeida, R.N.,2005. Neuroleptic-likeproperties ofthechloroform extractofMaytenusobtusifoliaMart.roots.Biol.Pharm.Bull.28,224–225.

Spivey,A.C.,Weston,M.,Woodhead,S.,2002.Celastraceaesesquiterpenoids: bio-logicalactivityandsynthesis.Chem.Soc.Rev.31,43–59.

Su,J.,Zhao,P.,Kong,L.,Li,X.,Yan,J.,Zeng,Y.,Li,Y.,2013.Trichothecininduces celldeathinNF-KBconstitutivelyactivatedhumancancercellsviainhibitionof IKK␤phosphorylation.PLoSONE8,1–8.

Subarnas,A.,Wagner,H.,2000.Analgesicandanti-inflammatoryactivityonthe proanthocyanidinshellegueainAfromPolypodiumfeeiMett.Phytomedicine7, 401–405.

Torpocco,V.,Cháve,H.,Estévez-Braun,A.,Ravelo,A.G.,2007.Newdammarane triter-penesfromMaytenusmacrocarpa.Chem.Pharm.Bull.55,812–814.

Torres-Romero,D.,King-Díaz,B.,Jiménez,I.A.,Lotina-Hennsen,B.,Bazzocchi,I.L., 2008.SesquiterpenesfromCelastrusvulcanicolaasphotosyntheticinhibitors.J. Nat.Prod.71,1331–1335.

Valerio,M.,Awad,A.B.,2011.␤-Sitosteroldown-regulatessomepro-inflammatory signaltransductionpathwaysbyincreasingtheactivityoftyrosinephosphatase SHP-1inJ774A.1murinemacrophages.Int.Immunopharmacol.11,1012–1017.

Vargas, F.S.,Almeida, P.D.O., Boleti, A.P.A.,Pereira, M.M.,Souza, T.P., Vascon-cellos,M.C.,Nunes, C.V.,Pohlit,A.M.,Lima,E.S.,2016.Antioxidantactivity andperoxidaseinhibitionofAmazonianplantsextractstraditionallyusedas anti-inflammatory.BMCComplement.Altern.Med.,http://dx.doi.org/10.1186/ s12906-016-1061-9.

Veloso,C.C.,Rodrigues,V.G.,Azevedo,A.O.,Oliveira,C.O.,Gomides,L.F.,Duarte,L.P., Duarte,I.D.,Klein,A.,Perez,A.C.,2014a.AntinociceptiveeffectsofMaytenus imbricataMart.ex.Reissek(Celastraceae)rootextractanditstingenone con-stituent.J.Med.PlantsRes.8,68–76.

Veloso,C.C.,Rodrigues,V.G.,Ferreira,R.C.M.,Duarte,L.P.,Klein,A.,Duarte,I.D., Romero,T.R.L.,Perez,A.C.,2014b.Tingenone,apentacyclictriterpene,induces peripheral antinociceptiondue to opioidergic activation. PlantaMed. 80, 1615–1621.

Veloso,C.C.,Rodrigues,V.G.,Ferreira,R.C.M.,Duarte,L.P.,Klein,A.,Duarte,I.D., Romero,T.R.L.,Perez,A.C.,2015.Tingenone,apentacyclictriterpene,induces peripheralantinociceptionduetoNO/cGMPandATP–sensitiveK(+)channels pathwayactivationinmice.Eur.J.Pharmacol.755,1–5.

Vellosa,J.C.R.,Khalil,N.M.,Gutierres,V.O.,Santos,V.A.F.F.M.,Furlan,M.,Brunetti, I.L.,Oliveira,O.M.M.F.,2009.Braz.J.Pharm.Sci.45,99–107.

Vieira,A.M.,2013.EficáciadoextratoaquosodeMaytenusrigidaMart.(Celastraceae) nalesãogástricainduzidaporetanolemcamundongos:análisedo envolvi-mentodoóxidonítrico,prostaglandinas,receptoresopioidese␣-2adrenérgicos. Dissertac¸ãodeMestrado,ProgramadePós-graduac¸ãoemBiotecnologia, Univer-sidadeFederaldoCeará,Sobral,79p.

Xiong,J.,Kashiwada,Y.,Chen,C.-H.,Qian,K.,Morris-Natschke,S.L.,Lee,K.H.,Takaishi, Y.,2010.ConjugatesofbetulinderivativeswithAZTaspotentanti-HIVagentes. Bioorg.Med.Chem.18,6451–6469.

Wang, X.W.,Xie, H., 1999. C-1027:antineoplasticantibiotic. DrugFuture24, 991–997.

Imagem

Fig. 1. Mechanism of action proposed for tingenone. nNOS, neuronal nitric oxide sintase; l-Arg, l-arginine; NO, nitric oxide; GTP, guanosine triphosphate; cGMP, cyclic guanosine monophosphate; K ATP , channels for sensitive potassium ATP.

Referências

Documentos relacionados

o ocorrido com as gemas vegetativas.Desta forma, entende-se que a poda realizada mais tardiamente acarreta um desenvolvimento inicial mais lento da planta, apesar de

H„ autores que preferem excluir dos estudos de prevalˆncia lesŽes associadas a dentes restaurados para evitar confus‚o de diagn€stico com lesŽes de

Ousasse apontar algumas hipóteses para a solução desse problema público a partir do exposto dos autores usados como base para fundamentação teórica, da análise dos dados

Digno de nota é que o destaque dado pela imprensa literária aos escritos de Graciliano, seja antecipando a publicação de seus livros, seja ao comentá-los

O clima da região de acordo com Köppen é classificado como mesotérmico úmido e verão ameno (Cfb). Foi realizado o acompanhamento da maturação, por meio de coletas semanais

didático e resolva as ​listas de exercícios (disponíveis no ​Classroom​) referentes às obras de Carlos Drummond de Andrade, João Guimarães Rosa, Machado de Assis,

No entanto, cães mais velhos podem morrer de outras causas sem que a doença chegue a provocar sinais clínicos, tal como aconteceu com o cão 2 (McEwan, 2000a).. Nos três cães com

Uma vez produzidos, a maior parte dos radicais livres são removidos pelas defesas antioxidantes da célula que incluem enzimas e moléculas não enzimáticas.. A manutenção